BTG Pactual Global Asset Management’s Trillium Therapeutics Inc. TRIL Stock Holding History

BTG Pactual Global Asset Management’s Portfolio TRIL Stock Details TRIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-10,000	Closed	-$176K	–	166
2021 Q3	$176K	Buy	+10,000	New	+$117K	0.03%	146

Other funds holding TRIL

Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return

BTG Pactual Global Asset Management's TRIL Position: Q4 2021 in Review

BTG Pactual Global Asset Management sold out of Trillium Therapeutics Inc. (TRIL) in Q4 2021, closing a stake of 10,000 shares — an estimated $176K sold.

BTG Pactual Global Asset Management first reported a position in TRIL in Q3 2021 and held it in 1 quarter. The position peaked at $176K in Q3 2021. 2 funds tracked by Wall St. Rank hold TRIL as of Q4 2021.

BTG Pactual Global Asset Management reported no remaining Trillium Therapeutics Inc. position as of Q4 2021 after selling out during the quarter.
BTG Pactual Global Asset Management sold 10,000 Trillium Therapeutics Inc. shares in Q4 2021, an estimated $176K.
BTG Pactual Global Asset Management first reported a position in Trillium Therapeutics Inc. in Q3 2021 and held it in 1 quarter.
BTG Pactual Global Asset Management's Trillium Therapeutics Inc. position peaked at $176K in Q3 2021.
2 funds tracked by Wall St. Rank held Trillium Therapeutics Inc. as of Q4 2021.

Based on BTG Pactual Global Asset Management's 13F filing for Q4 2021, filed 9 Feb 2022.